US Stock MarketDetailed Quotes

COLL Collegium Pharmaceutical

Watchlist
  • 35.320
  • +0.670+1.93%
Close Aug 8 16:00 ET
1.14BMarket Cap13.28P/E (TTM)

Collegium Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Collegium Pharmaceutical Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Aug 8, 2024

Revenue(YoY)

145.28M

+7.18%
EPS(YoY)

0.52

+52.94%
Analyst Rating

Buy

Jul 31, 2024

Collegium Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 172.821M--
--2024/Q3-- / 148.658M--
Aug 8, 20242024/Q2145.276M / 144.562M--
May 9, 20242024/Q1144.923M / 146.937M--
Feb 22, 20242023/Q4149.745M / 147.544M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 172.821M--
--2024/Q3-- / 148.658M--
Aug 8, 20242024/Q2145.276M / 144.562M--
May 9, 20242024/Q1144.923M / 146.937M--
Feb 22, 20242023/Q4149.745M / 147.544M--

Unlock Free Earnings Estimates

Collegium Pharmaceutical Earnings Reports

  • Collegium Pharmaceutical | 10-Q: Q2 2024 Earnings Report

    16:53 ET

  • Collegium Pharmaceutical | 10-Q: Q1 2024 Earnings Report

    May 9 16:17 ET

  • Collegium Pharmaceutical | 10-K: FY2023 Annual Report

    Feb 22 16:09 ET

  • Collegium Pharmaceutical: Q3 2023 Earnings Report

    Nov 7, 2023 16:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Buy

    • Buy

      60.00%

    • Hold

      40.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg